GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (TSX:VBV) » Definitions » Net Interest Income (for Banks)

VBI Vaccines (TSX:VBV) Net Interest Income (for Banks)


View and export this data going back to 2012. Start your Free Trial

What is VBI Vaccines Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


VBI Vaccines (TSX:VBV) Business Description

Industry
Traded in Other Exchanges
Address
160 Second Street, Floor 3, Cambridge, MA, USA, 02142
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.